Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Endocr Relat Cancer. 2012 Jan 9;19(1):29–38. doi: 10.1530/ERC-11-0155

Table 1.

Cell viability IC50 values for individual compounds in both MTC cell lines based on MTT assays

Compound TT cells (µM) MZ-CRC-1 cells (µM)
Sorafenib 0.17±0.04 6.87±0.13
Everolimus 6.39±0.75 14.69±0.28
AZD6244 6.35±1.07 >40

Values were obtained for experiments performed in duplicate on more than three separate occasions.